SO
WHWK

STRS Ohio’s Whitehawk Therapeutics WHWK Stock Holding History

STRS Ohio’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-155,500
Closed -$363K – 2119
2024
Q1 		$363K Buy
155,500
+148,900
+2,256% +$287K ﹤0.01% 1372
2023
Q4 		$13K Buy
6,600
+4,900
+288% +$20.6K ﹤0.01% 1866
2023
Q3 		$8K Buy
+1,700
New +$9.88K ﹤0.01% 1910
2022
Q4 		– Sell
-2,500
Closed -$35K – 2092
2022
Q3 		$35K Sell
2,500
-900
-26% -$11.8K ﹤0.01% 1876
2022
Q2 		$41K Buy
+3,400
New +$50.5K ﹤0.01% 1885

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

STRS Ohio's WHWK Position: Q2 2024 in Review

STRS Ohio sold out of Whitehawk Therapeutics (WHWK) in Q2 2024, closing a stake of 155,500 shares — an estimated $363K sold.

STRS Ohio first reported a position in WHWK in Q2 2022 and held it in 5 quarters. The position peaked at $363K in Q1 2024. 65 funds tracked by Wall St. Rank hold WHWK as of Q2 2024.

  • STRS Ohio reported no remaining Whitehawk Therapeutics position as of Q2 2024 after selling out during the quarter.
  • STRS Ohio sold 155,500 Whitehawk Therapeutics shares in Q2 2024, an estimated $363K.
  • STRS Ohio first reported a position in Whitehawk Therapeutics in Q2 2022 and held it in 5 quarters.
  • STRS Ohio's Whitehawk Therapeutics position peaked at $363K in Q1 2024.
  • 65 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2024.

Based on STRS Ohio's 13F filing for Q2 2024, filed 5 Aug 2024.